| Jagsonpal Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 507789 |
NSE Symbol : JAGSNPHARM |
P/E(TTM) : 30.03 |
|
ISIN Demat : INE048B01035 |
Div & Yield% : 1.30 |
EPS(TTM) : 6.36 |
|
Book Value(₹) : 37.77 |
Market Cap(₹Cr) : 1,278.98 |
Face Value(₹) : 2.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 72.95 | 74.47 | 75.61 | 58.56 | 74.03 | 74.69 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 72.95 | 74.47 | 75.61 | 58.56 | 74.03 | 74.69 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.98 | 3.03 | 2.83 | 2.77 | 25.51 | 1.65 |
| Total Income | 75.92 | 77.49 | 78.44 | 61.33 | 99.53 | 76.35 |
| Total Expenditure | 58.76 | 58.03 | 61.40 | 50.06 | 58.19 | 58.41 |
| PBIDT | 17.16 | 19.46 | 17.04 | 11.27 | 41.34 | 17.94 |
| Interest | 0.26 | 0.27 | 0.25 | 0.26 | 0.26 | 0.23 |
| PBDT | 16.91 | 19.20 | 16.78 | 11.01 | 41.09 | 17.71 |
| Depreciation | 2.39 | 2.39 | 2.35 | 2.31 | 2.41 | 2.34 |
| Tax | 3.75 | 3.81 | 3.17 | 1.24 | 8.06 | 2.68 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.18 | 0.43 | 0.47 | 0.89 | -1.38 | 1.23 |
| Reported Profit After Tax | 10.95 | 12.57 | 10.80 | 6.58 | 31.99 | 11.46 |
| Extra-ordinary Items | -1.54 | 0.00 | 0.00 | -0.16 | 18.35 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 12.49 | 12.57 | 10.80 | 6.74 | 13.64 | 11.46 |
| EPS (Unit Curr.) | 1.67 | 1.88 | 1.60 | 0.98 | 4.74 | 1.72 |
| EPS (Adj) (Unit Curr.) | 1.67 | 1.88 | 1.60 | 0.98 | 1.90 | 0.69 |
| Calculated EPS (Unit Curr.) | 1.64 | 1.89 | 1.62 | 0.99 | 4.84 | 4.33 |
| Calculated EPS (Adj) (Unit Curr.) | 1.64 | 1.89 | 1.62 | 0.99 | 1.94 | 1.73 |
| Calculated EPS (Ann.) (Unit Curr.) | 6.56 | 7.55 | 6.49 | 3.97 | 19.35 | 17.31 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 6.56 | 7.55 | 6.49 | 3.97 | 7.74 | 6.92 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 13.36 | 13.33 | 13.31 | 13.28 | 13.23 | 13.24 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 23.52 | 26.13 | 22.54 | 19.25 | 55.84 | 24.02 |
| PBDTM(%) | 23.18 | 25.78 | 22.19 | 18.80 | 55.50 | 23.71 |
| PATM(%) | 15.01 | 16.88 | 14.28 | 11.24 | 43.21 | 15.34 |
